Format

Send to

Choose Destination
J Cell Biochem. 2019 Jun 6. doi: 10.1002/jcb.28877. [Epub ahead of print]

Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.

Author information

1
Clinical Pharmacy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
2
Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, Iran.
3
Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
4
Sabinsa Corporation, New Jersey.
5
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
6
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
7
Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

BACKGROUND:

Nonalcoholic fatty liver disease (NAFLD) as a prevalent hepatic disease is associated with an increased risk of morbidity and mortality related to the liver and cardiovascular disease (CVD). Lifestyle modification and good metabolic control is the first line of treatment, but not always efficacious in reversing NAFLD pathogenesis. Curcumin is a dietary phytochemical with hepatoprotective activities, though its low bioavailability is considered as a major challenge for clinical applications. Therefore, in this study, in order to improve the bioavailability of curcumin, it was coadministered with piperine and we investigated the effects of this bioavailability-enhanced curcumin on serum hepatic enzymes, lipid profile, and glycemic indices in patients with NAFLD.

METHODS:

In this randomized controlled parallel-group trial, 70 subjects with ultrasound-determined NAFLD were randomized to either 500 mg curcuminoids coadministered with 5 mg piperine daily or placebo for 12 weeks. NAFLD severity (on the basis of sonography) and hepatic function was assessed at baseline and at the study end.

RESULTS:

Seventy subjects completed the study. Supplementation with curcuminoids plus piperine significantly reduced the hematocrit (P = 0.027), erythrocyte sedimentation rate (P = 0.048) and the serum concentrations of alanine aminotransferase (P = 0.035), aspartate aminotransferase (P = 0.042), alkaline phosphatase (P = 0.004), cholesterol (P < 0.016), low-density lipoprotein cholesterol (P < 0.017), Iron (P = 0.026), and Hemoglobin (P = 0.025) and increased total iron-binding capacity (P = 0.003). However, except albumin, changes in other parameters were not statistically different between groups. In addition, administration of curcuminoids plus piperine significantly improved NAFLD severity (P < 0.001), which was statistically different compared with the placebo group (P = 0.022). Also, the percentage of improved patients was marginally higher in the curcuminoids plus piperine group when compared with the placebo group (P = 0.058).

CONCLUSION:

This study suggested beneficial effects of combined curcuminoids and piperine supplementation on disease severity in patients with NAFLD.

KEYWORDS:

NAFLD severity; curcumin; hepatic enzymes; lipid profile; nonalcoholic fatty liver disease (NAFLD)

PMID:
31168845
DOI:
10.1002/jcb.28877

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center